XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2017
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
March 31,
2017
   
Range,
March 31,
2017
   
Weighted
Average,
March 31,
2016
   
Range,
March 31,
2016
 
Volatility
   
79%
     
78%
-
86%
     
74%
     
74%
 
Dividend yield
   
-
     
 
-
 
     
-
     
-
 
Risk-free interest rate
   
1.14%
     
0.82%
-
1.17%
     
1.75%
     
1.75%
 
Expected term (years)
   
4.0
     
3
-
4
     
5
     
5
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
   
Options
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2016
   
4,225,537
    $
1.79
     
4.1
    $
158,675
 
Granted
   
294,500
     
0.97
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
-
     
-
     
 
     
 
 
Outstanding at March 31, 2017
   
4,520,037
    $
1.42
     
3.2
    $
216,875
 
Exercisable at March 31, 2017
   
4,470,037
    $
1.43
     
3.2
    $
216,875
 
Schedule of Nonvested Share Activity [Table Text Block]
   
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2016
   
50,000
    $
0.76
 
Granted
   
294,500
     
0.52
 
Vested
   
(294,500
)    
(0.52
)
Nonvested at March 31, 2017
   
50,000
    $
0.46
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three
months
ended
March 31,
2017
   
Three
months
ended
March 31,
2016
   
Nine months
ended
March 31,
2017
   
Nine months
ended
March 31,
2016
 
General and administrative:
                               
Fair value of stock bonuses expensed
  $
-
    $
-
    $
6,830
    $
69,000
 
Change in fair value from modification of
option terms
   
-
     
-
     
166,031
     
42,550
 
Fair value of stock options expensed
   
6,134
     
1,486
     
112,699
     
65,695
 
Total
  $
6,134
    $
1,486
    $
285,560
    $
177,245
 
                                 
Research and development:
                               
Fair value of stock bonus expensed
  $
-
    $
-
    $
7,954
    $
-
 
Change in fair value from modification of
option terms
   
-
     
-
     
11,440
     
-
 
Fair value of stock options expensed
   
-
     
3,471
     
23,251
     
28,902
 
Total
  $
-
    $
3,471
    $
42,645
    $
28,902